Worth reading
57In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Neutral
Direction inferred from the company’s description.Scale
—
Displayed only when the document provides numerical figures.Wording
Conditional
How definitive the wording is.Decision and Details
Board of DirectorsContinuation of the stock-based compensation plan (the Plan) and partial revision of its terms
Decision12 May 2026
Period Covered3 consecutive fiscal years from fiscal 2026 through fiscal 2028
ImplementationThe Plan is scheduled to continue from fiscal 2026 onward. The trust agreement is scheduled to be entered into on 7 August 2026, and the trust period is scheduled to run from 1 September 2026 through the end of August 2029.
Going forwardA proposal concerning the Plan will be submitted to the 11th Annual General Meeting of Shareholders scheduled for 25 June 2026. The trust agreement is scheduled to be entered into on 7 August 2026, and the trust period is scheduled to commence on 1 September 2026. The total acquisition amount of the shares and other details will be disclosed once decided.
AmountAmount of additional trust funds: To be determined (to be disclosed once decided)
Quantity / scalePerformance-linked coefficient: 0–200%; 1 point: 1 share of the Company's stock; Company shares equivalent to 50% of the number of stock delivery points will be delivered (fractional shares below one trading unit will be discarded)
Reason
To support the directors and other officers of the Company and the directors of the covered operating companies in aligning their efforts to achieve the financial and non-financial targets under the Company-wide strategy, deepen sustained alignment of interests with shareholders, and reinforce their commitment to enhancing corporate value over the long term.
| Item | Details |
|---|---|
| Matter Covered | Continuation of the stock-based compensation plan (the Plan) and partial revision of its terms |
| Decision-Making Body | Board of Directors |
| Decision Date | 12 May 2026 |
| Implementation Date | The Plan is scheduled to continue from fiscal 2026 onward. The trust agreement is scheduled to be entered into on 7 August 2026, and the trust period is scheduled to run from 1 September 2026 through the end of August 2029. |
| Period Covered | 3 consecutive fiscal years from fiscal 2026 through fiscal 2028 |
| Amount | Amount of additional trust funds: To be determined (to be disclosed once decided) |
| Quantity / scale | Performance-linked coefficient: 0–200%; 1 point: 1 share of the Company's stock; Company shares equivalent to 50% of the number of stock delivery points will be delivered (fractional shares below one trading unit will be discarded) |
| Reason | To support the directors and other officers of the Company and the directors of the covered operating companies in aligning their efforts to achieve the financial and non-financial targets under the Company-wide strategy, deepen sustained alignment of interests with shareholders, and reinforce their commitment to enhancing corporate value over the long term. |
| Related previous disclosures | The Company's 9th Annual General Meeting of Shareholders held on 20 June 2024 (the 9th General Meeting of Shareholders) |
| Future plans | A proposal concerning the Plan will be submitted to the 11th Annual General Meeting of Shareholders scheduled for 25 June 2026. The trust agreement is scheduled to be entered into on 7 August 2026, and the trust period is scheduled to commence on 1 September 2026. The total acquisition amount of the shares and other details will be disclosed once decided. |
Items this document does not state (2)
Impact on Business PerformanceGoverning Rule
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To support the directors' unified efforts to achieve the financial and non-financial targets under the Company-wide strategy, deepen sustained alignment of interests with shareholders, and reinforce their commitment to enhancing corporate value over the long term.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.